Practical Dermatology

12/10/2025

🔎👨‍⚕️IN DEPTH: How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques? Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ. 🩺

📺 Watch here ➡️ https://ow.ly/ujQ850XGiCY

Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31,...

12/09/2025

📢 📰 NEW DERMWIRE TV: This episode highlights new research showing ruxolitinib cream 1.5% providing itch relief and broader atopic dermatitis (AD) improvement, as well as a post-hoc analysis finding safety and efficacy for stapokibart in elderly adults with AD; and Excellergy executives discuss how recent research validated effector cell response inhibitor's trifunctional mechanism of action.

📺 Watch here ➡️ https://ow.ly/1h0e50XGiI4

This episode highlights new research showing ruxolitinib cream 1.5% providing itch relief and broader atopic dermatitis (AD) improvement, as well...

12/09/2025

📢 📊 🧬 PSORRO UPDATE: New data from the PSORRO trial show that oral roflumilast was linked with the suppression of key proinflammatory cytokines, as well as reduced immune cell infiltration in psoriasis.

Read more ➡️ https://ow.ly/rITQ50XFUwr

12/08/2025

💊 💯 PROMISING THERAPIES ON THE AD HORIZON: Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important potential developments in the atopic dermatitis pipeline.

📺 Watch here ➡️ https://ow.ly/QP9W50XExNg

Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important...

12/06/2025

🩺 👩‍⚕️ BIOLOGIC USE IN CHILDREN WITH AD: Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric patients with AD. 👶 ✨

📺 Watch here ➡️ https://ow.ly/vEp850XExLV

Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the...

12/05/2025

👨‍⚕️☑️ MOISTURIZER BOOSTS SKIN BARRIER IN ACNE: A novel gel-matrix moisturizer designed for acne-prone skin improved barrier function and treatment tolerability in a new study.

Read more ➡️ https://ow.ly/CP1550XCPte

12/04/2025

🔎 🩺 💰IS THE PRICE RIGHT? A new randomized study embedded within the MEL-SELF trial suggests both low-cost and high-cost dermatoscopes enabled patients with a history of early-stage melanoma to effectively capture images for remote dermatologic assessment.

Read more ➡️ https://ow.ly/Rx1B50XC5tQ

12/03/2025

📢 NEW: A small proof-of-concept study indicates 80% of patients with moderate-to-severe hidradenitis suppurativa achieved HiSCR after 24 weeks on tirzepatide. Although early, the results suggest dual incretin therapy could offer a new treatment direction.

Read more ➡️ https://ow.ly/jkJj50XBAmU

12/02/2025

👀📰 FROM THE ISSUE: Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms? In the November/December issue of Practical Dermatology, contributor Graham Litchman, MD, tackles the question of whether prescription hyperhidrosis treatments mitigate symptoms.

✍️He writes: "Hyperhidrosis (HH) is more than a quality-of-life issue—it can significantly exacerbate dermatologic diseases including atopic dermatitis (AD), acne, psoriasis,rosacea, seborrheic dermatitis, cholinergic urticaria (CU), and hidradenitis suppurativa (HS). In patients with HH and one or more of these conditions, controlling excessive sweating may be an important adjunct to disease management."

Read the article ➡️ https://ow.ly/1gYo50XwH7H

Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.

12/01/2025

🔬 🤖 MACHINE LEARNING MODEL IMPROVES ACCURACY: A newly developed 14-gene model powered by machine learning offers a new tool for personalized prognosis in melanoma that outperforms current models, new study results suggest. The signature also highlights CUL2 as a key tumor suppressor. 👨‍⚕️🔎

Read more ➡️ https://ow.ly/E0Nw50XwH4f

11/29/2025

👩‍⚕️ 🙋‍♀️🙋‍♂️ASK ME ANYTHING MENTORSHIP SESSION: Sheila Barbarino, MD, FACS, provides insights on her career, her success using social media as a marketing tool for her practice, critical practice management issues, and much more.

📺 Watch here ➡️ https://ow.ly/atZI50XwqTh

Sheila Barbarino, MD, FACS, discusses the keys to her success using social media as a marketing tool for her practice, critical practice management...

11/28/2025

🆕 👩‍🔬 WHAT'S NEW IN DEVICES AND ADAPTOGENS: Jacqueline Watchmaker, MD, explores the intersection of medical devices and adaptogenic therapies in skincare. This video was recorded at the Science of Skin Summit in Austin, TX.

📺 Watch here ➡️ https://ow.ly/Mmge50Xwiw0

Jacqueline Watchmaker, MD, explores the intersection of medical devices and adaptogenic therapies in skincare. This video was recorded at the...